The Hockey-Stick Forecast Why Real Progress Beats Hockey Stick Growth

Will your business actually double in size overnight, or are you just sketching a fantasy? Most startup founders rely on hockey stick growth to entice backers, painting a picture of stagnant early years followed by a sudden, vertical surge in revenue. This forecasting method is so common that it's often treated as a necessary fiction in high-stakes fundraising. While these graphs look impressive on a projector screen, they often hide deep structural flaws that sink a company once reality sets in.

The Allure of the Vertical Line

In the book Bad Blood by John Carreyrou, this concept is famously illustrated through the experience of Henry Mosley, the former CFO of Theranos. Mosley was a veteran of the Silicon Valley scene who'd taken companies public and understood the 'game' of startup finance. He was pressured by Elizabeth Holmes to revise financial models upward until they showed revenue magically shooting up in a straight line. This visual representation of success is meant to show that a company has finally 'cracked the code' and is ready for infinite scale.

Every entrepreneur wants to show they're on the cusp of an explosion. In the world of hockey stick growth, the initial 'blade' of the stick represents the difficult years of research, development, and building a customer base. The 'handle' is the sharp upward trajectory that supposedly occurs once the product hits the market. It matters because it sets the valuation of the company, but it also creates a dangerous gap between promise and performance.

The Trap of Over-Optimistic Startup Financial Projections

Founders often feel they must present the most aggressive numbers possible to secure funding. Henry Mosley found himself in a position where the first set of numbers he created weren't to Elizabeth Holmes's liking, so he was forced to inflate them. He recognized that while venture capitalists expect a degree of overstatement, there's a limit to what's plausible. When projections are untethered from the actual readiness of the technology, the entire business model becomes a house of cards.

Why Founders Pivot to Hockey Stick Growth

The pressure to perform often leads to the 'fake it till you make it' culture that characterized the early days of Theranos. According to the book, the company's slide deck listed deals that would supposedly generate up to $300 million in revenue over 18 months. These figures were used to justify a $165 million valuation for a three-year-old startup. This strategy works as long as the underlying technology is functional, but it turns into fraud when the product is still a 'crapshoot.'

The Dangers of Magical Thinking in Revenue Forecasting

Financial models should be built from the bottom up, based on actual sales capacity and product milestones. In Mosley’s case, he agreed to ambitious numbers because he believed the blood-testing system worked reliably. When he discovered the team was faking results for investor demos, the hockey stick growth became a lie. Real growth is rarely a straight line; it involves setbacks, pivots, and the hard work of iterating on a product that people actually need.

The Fallout of Fabricated Milestones

At Theranos, the disconnect between the financial narrative and technical reality led to the firing of anyone who questioned the math. Henry Mosley was dismissed as 'not a team player' when he raised ethical concerns about faking demos to support his projections. The company eventually claimed it would reach $1.5 billion in revenue, numbers that were almost entirely fabricated. According to McKinsey research, only about 20% of high-growth companies manage to sustain their momentum over a decade, often because they can't bridge the gap between their initial hype and actual operations.

One clear example from the book is the Novartis demo in Switzerland. Elizabeth Holmes claimed the trip was perfect and that the drug giant was impressed enough to ask for a proposal. In reality, the hardware had malfunctioned, and the team had to beam over fake results from California to hide the failure. This type of deception is used to maintain the illusion that the company is on its upward trajectory, even when the 'handle' of the stick has broken off.

Another example is the $32 million funding round Theranos closed based on its supposed pharmaceutical agreements. These contracts were often 'under legal review' and never seen by the CFO himself. The valuation was built on the promise that the technology would reduce clinical trial costs by 30%. When the results didn't materialize, the company chose to fire its financial gatekeepers rather than fix its internal flaws.

Three Steps to Build Honest Growth Models

1. Use bottom-up accounting to verify your sales reach. Instead of claiming you'll capture 1% of a massive market, calculate how many units your current team can actually sell and ship each month. This grounds your forecast in the physical reality of your business.

2. Tie every revenue jump to a specific product milestone. Avoid showing a spike in year three without explaining exactly which feature or partnership will trigger it. Investors value a founder who understands the 'why' behind the numbers more than a founder who just draws steep lines.

3. Conduct regular internal 'pre-mortems' on your financial goals. Ask your team what would cause your revenue to stay flat instead of growing. Identifying these risks early allows you to build a more resilient company that doesn't rely on 'magical' spikes to survive.

Where Explosive Projections Fail the Reality Test

Critics of the 'hockey stick' model argue that it encourages dangerous behavior in high-stakes environments like biotech or healthcare. While a software company might be able to scale rapidly with a few server upgrades, medical hardware requires rigorous testing and regulatory approval. The 'move fast and break things' ethos doesn't work when you are dealing with patient lives and diagnostic accuracy.

Industry experts often point out that these projections are frequently used to hide a lack of product-market fit. By focusing on the imaginary surge in year five, founders avoid answering tough questions about their lack of traction in year one. This creates an environment where 'optimism' is used as a shield against accountability, eventually leading to the kind of ethical collapse seen at Theranos.

Sustainable success is measured by recurring income that covers your operations without constant infusions of capital. Prioritizing hockey stick growth over real-world execution turns a business into a performance rather than a service. Audit your current revenue model today and remove any spikes that aren't tied to a specific, verified milestone.